Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022)

Neurocrine Biosciences has reported Other Non Operating Income for 11 years, with the latest figure at -$70.0 million in Q2 2022.

• For the quarter ending Q2 2022, Other Non Operating Income changed N/A year-over-year to -$70.0 million; the trailing twelve-month figure through Jun 2023 stood at -$70.0 million (changed 0.0% YoY), and the FY2022 full-year result was -$70.0 million, changed N/A from the prior year.
• Other Non Operating Income for Q2 2022 stood at -$70.0 million, down from -$18.4 million in the prior quarter.
• The five-year high for Other Non Operating Income was $201000.0 in Q1 2018, with the low at -$70.0 million in Q2 2022.
• Historically, Other Non Operating Income has averaged -$22.0 million across 3 years, with a median of -$9.1 million in 2018.
• The largest YoY upside for Other Non Operating Income was 77.13% in 2018 against a maximum downside of 79.18% in 2018.
• Neurocrine Biosciences' Other Non Operating Income stood at $183000.0 in 2018, then slumped by 10154.64% to -$18.4 million in 2020, then plunged by 280.43% to -$70.0 million in 2022.
• The last three Other Non Operating Income figures came in at -$70.0 million (Q2 2022), -$18.4 million (Q4 2020), and $183000.0 (Q2 2018), per Business Quant data.